Pendal Group’s Zepp Health ZEPP Stock Holding History

Pendal Group’s Portfolio ZEPP Stock Details ZEPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-24,949	Closed	-$1.31M	–	524
2020 Q1	$1.31M	Buy	+24,949	New	+$1.35M	0.02%	195

Other funds holding ZEPP

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Pendal Group's ZEPP Position: Q2 2020 in Review

Pendal Group sold out of Zepp Health (ZEPP) in Q2 2020, closing a stake of 24,949 shares — an estimated $1.31M sold.

Pendal Group first reported a position in ZEPP in Q1 2020 and held it in 1 quarter. The position peaked at $1.31M in Q1 2020. 61 funds tracked by Wall St. Rank hold ZEPP as of Q2 2020.

Pendal Group reported no remaining Zepp Health position as of Q2 2020 after selling out during the quarter.
Pendal Group sold 24,949 Zepp Health shares in Q2 2020, an estimated $1.31M.
Pendal Group first reported a position in Zepp Health in Q1 2020 and held it in 1 quarter.
Pendal Group's Zepp Health position peaked at $1.31M in Q1 2020.
61 funds tracked by Wall St. Rank held Zepp Health as of Q2 2020.

Based on Pendal Group's 13F filing for Q2 2020, filed 7 Aug 2020.